EVERY BEAT MATTERS.
The first home fetal-ECG device for high-risk pregnancies. Continuous monitoring. Early hypoxia detection. Outside the hospital.
THE MONITOR STAYS AT THE HOSPITAL. THE RISK DOESN'T.
Fetal hypoxia develops silently, with no symptoms the mother can feel. Hospitals already handle high-risk cases with great care — what's missing is continuity between one visit and the next.
Nearly 1 in 3 pregnancies in developed countries is classified as high-risk — driven by maternal age, BMI, hypertension, diabetes, prior loss or ART. Yet no device exists for continuous fetal monitoring at home.
Fetal heart monitoring only happens during hospital visits or labour. Between appointments, the rest of gestation is a clinical blind spot.
Wearables track the mother's steps, sleep and heart rate — but nothing continuously monitors the baby between appointments. Expectant mothers go home with no way to know.
CLINICAL
GRADE.
AT HOME.
A wearable circular array of ECG sensors on the maternal abdomen continuously captures fetal heart signals, turning them into clinically interpretable data — accessible remotely by healthcare professionals.
Circular ECG sensor array
A multi-electrode array placed on the maternal abdomen captures fetal electrocardiographic signals, regardless of fetal position or maternal movement.
Fetal signal extraction
Advanced algorithms separate fetal from maternal ECG signals, isolating the fetal heart trace with clinical-grade accuracy.
Continuous home monitoring
24/7 fetal heart monitoring outside the hospital. The mother carries on with her daily activities — no need to stay seated or immobile.
Connected clinical platform
Fetal data is transmitted to EmbryoMonitor, a cloud platform where healthcare professionals remotely review trends and receive alerts.
Early distress detection
Clinically interpretable indicators — heart-rate variability, rhythm patterns — help detect early signs of fetal hypoxia. Every alert is reviewed by a professional before it reaches the mother. No false alarms.
Medical-grade by design
Embryo is being developed as a medical device from day one, with CE marking as the target regulatory pathway. Clinical validation and certification are core milestones on our roadmap.
Technical documentation available under NDA for qualified investors and partners.
NOT TO HIDE. TO SHINE.
Embryo isn't something to hide under your shirt. It's something to wear because you're proud to be expecting — a personal object, not a clinical kit.
EmbryoMonitor — the other half of the product.
A single telemedicine platform for continuous fetal monitoring and trace review, with AI-supported, inspectable diagnosis — no black box.
AWARD-WINNING BY DESIGN.
MASSIVE. UNTAPPED. NOW.
Growing at 10.1% CAGR — home monitoring is the fastest-growing segment. TAM €3.1B global · SAM €90M in Europe.
We start where risk is highest — 333 clinics in Italy alone. Embryo goes to market B2B2C: from clinic, to mother, monitored at home.
Nobody has ever done this before. Details only on a call — book a meeting to find out.
THE PEOPLE
BEHIND THE
HEARTBEAT.
Biomedical engineering, product design and financial strategy — united by one mission: making fetal monitoring accessible to every high-risk pregnancy.
Leading EMBRYO's vision, strategy and clinical partnerships, driving the first home-based fetal ECG system from concept to prototype.
Responsible for the wearable device design, material selection and form-factor engineering. Expertise in advanced textiles and medical-grade wearables.
Former European Central Bank professional. Managing all financial aspects — from planning and investor relations to fundraising strategy.
Leads fetal-ECG signal processing — isolating the fetal heart trace from maternal noise with clinical-grade accuracy.
Builds the AI architecture behind EmbryoMonitor — inspectable diagnostics with no black box.
OUR
ADVISORS.
Guided by world-class professors and industry leaders — bringing academic rigor and strategic expertise to every stage of the project.
JOIN THE
MISSION.
We are raising our Pre-Seed round to complete device validation, regulatory filing, and first clinical partnerships. Let's talk.
CONTACT US.
Have a question, a partnership idea, or just want to say hello? Drop us a message and we'll get back to you.
THANK YOU.
Your message is ready in your mail app. We'll get back to you as soon as possible.
{{ modalTitle }}
{{ modalSub }}
REQUEST SENT.
Thanks — we've received your request and will get back to you shortly. Check your inbox for a confirmation email.